Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Return on Assets (2016 - 2017)

Historic Return on Assets for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q3 2017 value amounting to 0.3%.

  • Eledon Pharmaceuticals' Return on Assets rose 7800.0% to 0.3% in Q3 2017 from the same period last year, while for Sep 2017 it was 0.3%, marking a year-over-year increase of 7800.0%. This contributed to the annual value of 1.1% for FY2016, which is 5800.0% down from last year.
  • Eledon Pharmaceuticals' Return on Assets amounted to 0.3% in Q3 2017, which was up 7800.0% from 0.64% recorded in Q2 2017.
  • In the past 5 years, Eledon Pharmaceuticals' Return on Assets registered a high of 0.22% during Q4 2014, and its lowest value of 2.25% during Q1 2017.
  • Over the past 4 years, Eledon Pharmaceuticals' median Return on Assets value was 0.63% (recorded in 2015), while the average stood at 0.82%.
  • The largest annual percentage gain for Eledon Pharmaceuticals' Return on Assets in the last 5 years was 7800bps (2017), contrasted with its biggest fall of -15600bps (2017).
  • Quarter analysis of 4 years shows Eledon Pharmaceuticals' Return on Assets stood at 0.22% in 2014, then plummeted by -185bps to 0.62% in 2015, then crashed by -223bps to 2.0% in 2016, then skyrocketed by 85bps to 0.3% in 2017.
  • Its last three reported values are 0.3% in Q3 2017, 0.64% for Q2 2017, and 2.25% during Q1 2017.